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Bacterial toxin-antitoxin (TAs) loci usually consist of two genes organized as an operon, 
where their products are bound together and inert under normal conditions. However, under 
stressful circumstances the antitoxin, which is more labile, will be degraded more rapidly, 
thereby unleashing its cognate toxin to act on the cell. This, in turn, causes cell stasis or cell 
death, depending on the type of TAs and/or time of toxin exposure. Previously based on in 
silico analyses, we proposed that Streptococcus pneumoniae, a pathogenic Gram-positive 
bacterium, may harbor between four to ten putative TA loci depending on the strains. Here we 
have chosen the pneumococcal strain Hungary19A-6 which contains all possible ten TA loci. 
In addition to the three well-characterized operons, namely relBE2, yefM-yoeB, and pezAT, 
we show here the functionality of a fourth operon that encodes the pneumococcal equivalent 
of the phd-doc TA. Transcriptional fusions with gene encoding Green Fluorescent Protein 
showed that the promoter was slightly repressed by the Phd antitoxin, and exhibited almost 
background values when both Phd-Doc were expressed together. These findings demonstrate 
that phd-doc shows the negative self-regulatory features typical for an authentic TA. Further, 
we also show that the previously proposed TAs XreA-Ant and Bro-XreB, although they 
exhibit a genetic organization resembling those of typical TAs, did not appear to confer a 
functional behavior corresponding to bona fide TAs. In addition, we have also discovered new 
interesting bioinformatics results for the known pneumococcal TAs RelBE2 and PezAT. A 
global analysis of the four identified toxins-antitoxins in the pneumococcal genomes (PezAT, 
RelBE2, YefM-YoeB, and Phd-Doc) showed that RelBE2 and Phd-Doc are the most 
conserved ones. Further, there was good correlation among TA types, clonal complexes and 
sequence types in the 48 pneumococcal strains analyzed.  
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Toxins-antitoxins (TAs) were discovered in the early 1980s and, later on, their cellular 
function was extensively studied especially in the past two decades. However, until now the 
world of TAs is still perplexing. TAs are found abundantly in prokaryotes, especially in free-
living bacteria, as well as in archaea, and probably in fungi but so far, not in other eukaryotes 
(Pandey and Gerdes, 2005). In general, a TA locus consists of two genes organized as an 
operon, with the antitoxin gene, which is generally precedes the toxin gene, encoding either 
an untranslated RNA or a labile protein that neutralizes the toxicity of its cognate toxin, 
whereas the toxin gene encodes a toxin protein that binds to the cellular targets and halts 
essential cell processes. Under certain circumstances such as stress, the system would be 
triggered by a rapid degradation of the antitoxin, thus liberating the toxin to act on its target. 
Most known toxins function as RNases (Christensen et al., 2001;Nariya and Inouye, 
2008;Jørgensen et al., 2009;Yamaguchi and Inouye, 2009), whereas other toxins target 
essential cellular components such as DNA gyrase (van Melderen, 2002), cell wall (Mutschler 
et al., 2011), and EF-Tu elongation factor (Castro-Roa et al., 2013). TAs have been classified 
into five types, depending on how the antitoxin counteracts the toxin. Type II TAs, in which 
the antitoxin is a protein that binds avidly to the toxin protein to form an inert complex, are 
the most widely studied (Makarova et al., 2009;Leplae et al., 2011). When found on plasmids, 
TAs function primarily in the stable maintenance of the plasmid, post-segregationally killing 
off any plasmid-free daughter cells that developed. The functions of the chromosomally-
encoded bacterial TAs are still intriguing. They might not be essential, but they have been 
reported to be involved in a variety of cellular processes related to global stress responses 
(Christensen et al., 2001), programmed cell death (Engelberg-Kulka and Glaser, 1999), 
maintenance of mobilomes (Rowe-Magnus et al., 2003;Szekeres et al., 2007), persistence 
(Gerdes and Maisonneuve, 2012), biofilm formation (Harrison et al., 2009;Soo and Wood, 
2013), niche colonization (Norton and Mulvey, 2012), virulence (Ren et al., 2012), phage 
abortive infection system (Fineran et al., 2009;Dy et al., 2014), and other important cellular 
processes (Goeders and Van Melderen, 2014). Some bacterial genomes are bountiful in TAs, 
e.g. Mycobacterium tuberculosis encodes 30 functional TAs (Ramage et al., 2009), which 
makes their intricacy bewildering. The ability of TAs to impart growth control may attribute 
to the slow growth and dormant state, which are the hallmarks of latent tuberculosis infection 
(Schifano and Woychik, 2014), but the mechanisms involved, and how many TAs may be 
responsible for these phenotypic traits are still unknown. It is still unclear whether the TAs 
within the same host could cross-talk. However, some studies have shown that expression of 
one TA might activate another (Garcia-Pino et al., 2008). Whether numerous TAs would 
provide cumulative or synergistic effect to the cells is something worth to ponder. 
 
 Streptococcus pneumoniae (the pneumococcus) is a Gram-positive bacterium, 
pathogenic for humans and responsible for both infections in respiratory tracts as well as 
invasive infections, and associated with significant morbidity and mortality (Chan et al., 
2012). Furthermore, clinical isolates of pneumococci show a high degree of variability, 
probably due to the recombinogenic nature of this bacterium (Claverys et al., 2006;Baquero, 
2009). We had previously identified up to 10 putative Type II pneumococcal TAs based on in 
silico data mining (Chan et al., 2012), and three of them had already been proven to be 
functional, namely relBE2, yefM-yoeB, and pezAT (Chan et al., 2013). Here, we have 
undertaken the validation and characterization of the rest of the putative pneumococcal TAs. 
We show that S. pneumoniae encodes a fourth functional TA operon, phd-doc, which 
corresponds to a bona fide TA. Further, we experimentally ruled out some of the predicted 
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pneumococcal gene pairs as typical TAs, since some of these putative toxins turned out to be 
either non-toxic, or possibly toxic but lacking a cognate antitoxin gene.  
 
 
2. Materials and Methods 
 
2.1. Bacterial strains and growth conditions 
 
S. pneumoniae R6 (Hoskins et al., 2001) and Escherichia coli Top10 [F¯ mcrAΔ(mrr-
hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araAleu)7697 
galUgalKrpsL(Strr) endA1 nupG] were used as homologous and heterologous hosts for 
verification of putative TAs from S. pneumonia Hungary19A-6 (McGee et al., 2001) via 
overexpression assays. S. pneumoniae R6 was grown in AGCH medium (Lacks, 1968) with 
0.3% sucrose and 0.2% yeast extract at 37 °C in static water bath, and supplemented with 
erythromycin (1 μg/ml) or tetracycline (1 μg/ml) when the cells harbored recombinant 
plasmids pLS1ROM-MCS  (Lacks et al., 1986;Ruiz-Masó et al., 2012) or pAST (Ruiz-Cruz 
et al., 2010), respectively. E. coli cultures were grown in TY medium (Sambrook and Russel, 
2001), at 37°C with agitation at 250 rpm (for liquid medium), and supplemented with 
kanamycin (50 μg/ml) when the cells harbored plasmid pFUS2 (Lemonnier et al., 2003) or its 
derivatives.  
 
2.2. DNA manipulations, sequencing, and sequence data analysis 
 
DNA manipulations and other molecular biology techniques were done following standard 
protocols (Sambrook and Russel, 2001). S. pneumoniae genomic DNA was extracted using 
the Bacterial Genomic DNA Isolation Kit (Norgen Biotech Corp.). Plasmid DNA from both 
S. pneumoniae and E. coli was isolated using the High Pure Plasmid Isolation kit (Roche). 
However, for S. pneumoniae, the plasmid extraction protocols were slightly modified as 
described (Ruiz-Cruz et al., 2010). DNA fragments and PCR products were purified with the 
NZYGelpure from NZYTech. DNA was sent for automated Sanger sequencing in Secugen 
S.L., Centro de Investigaciones Biológicas, CSIC, Madrid. DNA sequences were analyzed 
using the BioEdit Sequence Alignment Editor version 7.0.4.1 (Hall, 1999).  
 
2.3. Construction of recombinant plasmids with S. pneumoniae Hungary19A-6 putative 
TAs 
 
All plasmids and primers used in this study are shown in Table 1, and the details are described 
below. 
 
2.3.1. pLS1ROM-MCS derivatives 
 
Seven putative pneumococcal TA genes from strain Hungary19A-6 (GI: 169832377) (Chan et 
al., 2012) were verified in the S. pneumoniae homologous host. Plasmid pLS1ROM-MCS 
(Lacks et al., 1986;Ruiz-Masó et al., 2012), which was derived from the streptococcal 
promiscuous plasmid pMV158 (Espinosa, 2013), harbors a tight maltose-inducible promoter 
PM. The pneumococcal putative toxin genes along with their Shine-Dalgano (SD) sequences 
were cloned downstream of promoter PM, and then transformed (Lacks, 1968) into S. 
pneumoniae R6 for overexpression assays. The seven putative toxin genes were: relE1 (GI: 
169832900), hicA (GI: 169834067), genes COG2856CA (GI: 169832377 and 169833989), 
gene COG2856B (GI: 169832735), doc (GI: 169833045), ant (antirepressor) (GI: 151 
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 169833276; previously known as bro1 (Chan et al., 2012)) and bro (baculovirus repeated 
o
152 
rfs) (GI: 169834001; previously known as bro2 (Chan et al., 2012)). In the case of the doc 
gene, its SD sequences were not apparent and thus we decided to use the SD sequences of its 
cognate antitoxin phd. Consequently, those which exhibited toxicity to the cells, i.e. doc, ant 
and bro, were further analyzed by cloning their cognate putative antitoxins phd (GI: 
169832994), xreA (GI: 169832832; previously known as xre (Chan et al., 2012)) and xreB 
(GI: 169834410; previously known as xre (Chan et al., 2012)), as well as both putative TA 
operons along with their SD, respectively, into pLS1ROM-MCS, and then subjected to 
overexpression assays. 
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2.3.2. pFUS2SD and derivatives 
 
The arabinose-inducible plasmid pFUS2 (Lemonnier et al., 2003) was used to construct 
recombinant plasmids with the seven putative toxins from S. pneumoniae Hungary19A-6 (as 
described above) to validate their functionality in E. coli heterologous host. Since TA operons 
are usually co-transcribed and some of the toxin genes which are located downstream of the 
antitoxin genes do not have an obvious SD sequence, we had constructed plasmid pFUS2SD 
(this study) by inserting an SD consensus sequence (AGGAGG) downstream of the 
arabinose-inducible PBAD promoter of pFUS2 by reverse PCR and then self-ligation. This 
recombinant plasmid was subsequently used for the cloning of the seven putative toxin genes 
from Hungary19A-6 strain. In addition, the known toxin yoeB (GI: 15903627) from S. 
pneumoniae R6 was also constructed in pFUS2SD to serve as a positive control (Chan et al., 
2011). All these genes were inserted at the EcoRI restriction site downstream of the SD 
sequence, and thus the start codons of all these genes were 6 bp apart from the SD sequence. 
The recombinant plasmids were transformed into E. coli Top10 (Sambrook and Russel, 2001) 
and used to conduct overexpression assays. 
 
2.3.3. pAST derivatives 
 
To verify the promoter activities and to characterize the transcriptional regulation of the 
promoter by pneumococcal Phd and Phd-Doc, transcriptional fusions were constructed to 
measure Green Fluorescent Protein (GFP) fluorescence. Plasmid pAST (Ruiz-Cruz et al., 
2010), which harbors a promoter-less gfp gene was used for this study. The putative promoter 
of the phd-doc operon, the phd gene along with its promoter and the phd-doc genes along with 
their promoter were inserted upstream of the gfp gene of pAST plasmid, respectively. All the 
recombinant plasmids were transformed into S. pneumoniae R6 and then to evaluate the 
promoter activities by measuring GFP fluorescence. 
 
2.4. Overexpression assays of putative TAs in S. pneumoniae and E. coli 
 
Cell cultures of S. pneumoniae R6 harboring the different recombinant plasmids were grown 
in AGCH medium supplemented with 0.3% sucrose and 0.2% yeast extract (Lacks et al., 
1986) until optical density (OD)650~0.3 and subsequently subcultured to OD650 of ~0.02 in the 
same medium but with addition of 0.2% maltose to induce promoter PM. OD of the cultures 
was measured every hour for 8 h. E. coli Top10 with different recombinant plasmids were 
inoculated in TY medium (Maniatis et al., 1982) supplemented with 0.4% glucose to repress 
expression from the PBAD promoter, and the cells were allowed to grow until OD600 of ~0.3. 
Cells were harvested and washed twice with TY medium, followed by suspension in TY 
medium to OD600 of ~0.02, and then induced with 0.4% arabinose. The assays were repeated 
three times and the mean values and the standard errors were calculated. 
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2.5. GFP Fluorescence assays 
 
To characterize the promoter activities of pneumococcal phd-doc, fluorescence assays were 
conducted as previously described (Ruiz-Cruz et al., 2010). Briefly, S. pneumoniae carrying 
recombinant plasmids with various gfp-fusions were grown until OD650~0.3. Various volumes 
of cells (25 µl to 1 ml) were harvested and resuspended in 200 µl 1× PBS buffer in a 96-well 
black plate, respectively. Fluorescence was measured with a Varioskan Flash Spectral 
Scanning Multimode Reader (Thermoscientific) by excitation at 488 nm with a bandwidth of 
12 nm and detection of emission at 515 nm. Three independent cultures were analyzed and 
results of 1 ml of cultures were chosen to show in this manuscript. The cells were also 
subsequently used for microscopy examination. 
 
2.6. Cell morphology examination with phase-contrast and fluorescence microscopy 
 
Cells from overexpression assays were harvested at 4 h and 8 h after induction. Cells were 
washed twice with 1× PBS, resuspended in 4% paraformaldehyde and fixed at room 
temperature for 30 min. Cells were again washed once with 1× PBS buffer and resuspended in 
the same buffer. The fixed cells were placed on polylysine coated microscope slides, air-dried 
and mounted with Vectashield (Vector Laboratories) before being covered with cover slides, 
and sealed with nail polish. The cells were examined under microscope (Olympus CKX41), 
and pictures were taken at 100× magnification. To examine pneumococcal cells harboring 
various gpf-fused promoter-phd-doc recombinant plasmids, 10 µl of cells in 1× PBS buffer 
from Section 2.5 were viewed under the phase-contrast and fluorescence microscopy. Pictures 
were taken at 100× magnification, 200 ms. 
 
2.7. Bioinformatics analyses 
 
Genome databases in NCBI (http://www.ncbi.nlm.nih.gov/) and Pfam 
(http://pfam.sanger.ac.uk/) were used for bioinformatics analyses. Sequence alignments were 
conducted using web tool Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) and the 
BioEdit Sequence Alignment analytical software, whereas neighbor-joining phylogenetic 
trees were generated with Composition Vector Tree Version 2 
(http://tlife.fudan.edu.cn/cvtree/) and MEGA6.05. A web-based resource for bacterial 
integrative and conjugative elements (ICEs) termed ICEberg (http://db-
mml.sjtu.edu.cn/ICEberg/) (Bi et al., 2012) was used to detect the presence of TAs in 
pneumococal ICEs. PHAST (PHAge Search Tool) (http://phast.wishartlab.com/) (Zhou et al., 
2011) was used to identify TAs in prophage sequences within pneumococcal genomes. In the 
case of strains, whose sequence types (STs) were not directly available, sequences of seven 
loci used in the multilocus sequence typing (MLST) scheme (Enright and Spratt, 1998) were 
retrieved from genomic data and submitted to the online database  
http://pubmlst.org/spneumoniae/ (28th August 2014, date last accessed) to obtain allele 
numbers and STs. Position of the STs was then analyzed for all strains within the population 
snapshot, constructed based on the content of the whole MLST database (28th August 2014, 
date last accessed) using the eBURST approach (Feil et al., 2004) at http://eburst.mlst.net/ and 
resulting clonal complexes (CCs) were named based on the predicted founder of the group. 
The largest observed CC, including ST156 as a proposed primary founder, was additionally 
divided into lineages named according to the predicted secondary founders.   
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3.1. Verification of the putative TAs from S. pneumoniae Hungary19A-6 in S. pneumoniae 
R6 and in E. coli Top10 
 
Between four to 10 putative TAs were found in our previous in silico analysis of S. 
pneumoniae genomes (Chan et al., 2012). Genes of the putative TAs analyzed here were 
derived from the Hungary19A-6 strain. It is a pathogenic strain, which harbors all 10 putative 
TA pairs, thus covering most (if not all) of the putative pneumococcal TAs reported to date. 
Three out of the 10 TA operons, namely the R6 strain relBE2, yefM-yoeB and pezAT, had 
been previously shown to encode functional TAs in S. pneumoniae and also in E. coli (Nieto 
et al., 2006;Khoo et al., 2007;Nieto et al., 2007). Thus, these three pairs were not included 
here, with the exception of the yoeB toxin gene that was used as a positive control for the 
overexpression assays in the E. coli host.  
 
 The functionality of the seven putative toxins was first analyzed in their natural host S. 
pneumoniae and the ones that retarded cell growth were further analyzed with their cognate 
antitoxins. In the case of the pneumococcal doc gene, the construction of plasmid pLS1ROM-
MCS harboring doc had a mutation at the SD in which ´AGGAGG´ was changed to 
´AGGC
270 
GG´. However, this mutation did not hinder Doc protein to exhibit its toxicity to the 
cell. Overproduction of Doc had strongly retarded the growth of S. pneumoniae despite the 
growth resumed after 6 h (Figures 1A). Nonetheless, its toxicity could be clearly neutralized 
by co-expression of its cognate antitoxin Phd in cis (Figures 1B). This finding demonstrated 
that the pneumococcal phd-doc pair constitutes a bona fide functional TA. For Ant and Bro, 
cell growth was also inhibited when the proteins were overproduced, respectively, albeit less 
toxic than Doc (Figure 1A). Growth of S. pneumoniae cells resumed after a few hours of 
induction of the toxins (Figure 1A), indicating the toxicity was temporal. Unexpectedly, co-
expression of their presumptive cognate antitoxins XreA and XreB did not neutralize the 
toxicity of Ant and Bro, respectively (Figure 1B). Expression of XreA and XreB alone was 
not toxic to the cells, but intriguingly, the pairs XreA-Ant and Bro-XreB seemed to be slightly 
more toxic to the cells, compared to the Ant and Bro toxins alone (Figure 1B). Conversely, 
overproduction of the rest of the putative pneumococcal toxins HicA, RelE1, COG2856CA 
and COG2856B had no effect on the growth of S. pneumoniae (Figure 1A).   
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 In the case of the heterologous host E. coli, as in their native host S. pneumoniae, 
overexpression of HicA, RelE1, COG2856CA and COG2856B were inert to the cells (Figure 
1C). We were unable to obtain the recombinant plasmid of pFUS2SD with the putative 
pneumococcal toxin doc gene, most likely because of its high toxicity to the host. As it was 
observed for YoeB, overexpression of the Ant and Bro proteins led to suppression of the 
growth of E. coli; moreover, in contrast to S. pneumoniae, no indication that the cultures 
resumed growth was found even after 8 h of incubation, indicating that both proteins were 
very toxic to the host (Figure 1C). 
 
 We conclude that out of the seven gene pairs that we had investigated here, only Phd-
Doc was demonstrated to be a bona fide pneumococcal TA. Concerning Ant and Bro, 
overexpression of each of these proteins inhibited growth of both S. pneumoniae and E. coli; 
however, the products of their adjacent genes XreA and XreB were unable to counteract their 
toxicity, respectively. Therefore, we do not classify them as typical TA pairs. Thus, we have 
re-evaluated the number of functional bona fide TAs for the 48 pneumococcal strains whose 
genomic sequences are available in the NCBI genome databases (Table 2, see below). 
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3.2. The pneumococcal Phd-Doc: the fourth functional TA pair in S. pneumoniae 
 
As mentioned above, the pneumococcal Doc was shown to be toxic to its natural host, and co-
expression of the cognate Phd antitoxin was able to counteract the toxicity of Doc. The 
pneumococcal phd-doc gene pair was present in a single copy in almost all the genomes of 
pneumococcal strains examined (43 out of 48 strains; Table 2) (Chan et al., 2012). The phd-
doc genes are structured as an operon, which was consistently surrounded by genes encoding 
Type I restriction-modification systems; further, a gene that encodes a putative 
integrase/recombinase was also conserved downstream of doc (Figure 2A). However, the 
genomic context of phd-doc was not entirely conserved since, in some strains, transposases 
were also evident further downstream. The pneumococcal phd antitoxin and doc toxin genes 
overlap by four nucleotides and both genes are likely co-transcribed from a single promoter 
located upstream of phd (Figure 2A). An inverted repeat of 8 nt (GTAA·TTAC) was 
identified, which partly covered the ‒35 consensus sequences (Figure 2A). This differs from 
the promoter of phd-doc of bacteriophage P1, in which two palindrome sequences 
(TGTGT·ACACA and CGAGT·ACACG) were found to be located between the ‒ 10 
consensus sequence and the start codon of Phd, with one of the palindromes overlapping the 
SD (Magnuson et al., 1996). We postulate that the inverted repeat would function as the 
operator where the pneumococcal Phd antitoxin binds to repress its own transcription, as in 
other TAs (Magnuson et al., 1996;Tian et al., 2001;Kedzierska et al., 2007). To test the 
regulation of transcription of pneumococcal Phd-Doc, we constructed a set of pneumococcal 
plasmids based on the pAST promoter-probe vector that harbors the gfp gene (Ruiz-Cruz et 
al., 2010). Thus, transcriptional fusions allowed us to measure the phd-doc promoter. In 
addition, and to demonstrate whether Phd antitoxin and the Phd-Doc pair regulate their 
transcription, either the antitoxin or the TA pair was fused to the promoter-less gene encoding 
GFP. Measurement of the levels of fluorescence showed that indeed the promoter region 
resulted in GFP expression of ~8 arbitrary units, which were slightly repressed by synthesis of 
the antitoxin (~6 arbitrary units) and repressed further to ~1 arbitrary units (down to nearly 
basal levels ~0.1 arbitrary units) by the joint production of the Phd-Doc pair (Figure 2B). In 
agreement to these results, observation of these cells under phase-contrast and fluorescence 
microscopy also demonstrated that the fluorescence was not much different for cells 
harboring promoter-gfp and promoter-phd-gfp; whereas the fluorescence of cells harboring 
promoter-phd-doc-gfp was visibly lower (Figure 2C). Employment of the GFP reporter to 
detect TA activation was previously shown for the Salmonella sehAB operon (De la Cruz et 
al., 2013). In our case, it has turned out to be a simple and reliable way to show auto-
repression of the phd-doc operon. Further, it could be used for any of the TA to be tested and 
also to perform in vivo studies on conditions that trigger any particular TA. To our 
understanding, this is the first time that this strategy is performed for a Gram-positive 
bacterium.  
 
 Like other Doc homologs, the pneumococcal Doc has a Fic (filamentation induced by 
c
343 
yclic AMP) domain (Utsumi et al., 1982) at the N-terminal moiety. In general, the conserved 
Fic motif, HxFx(D/E)GNGRxxR (Engel et al., 2012;Goepfert et al., 2013), possesses 
adenylylation (or “AMPylation”) activity (Itzen et al., 2011;Woolery et al., 2012). By 
comparison, the consensus residues of the Fic motifs in all Doc toxins are slightly different, 
HxFx(D/N)(A/G)NKR (Cruz et al., 2014), as is the pneumococcal Fic motif HVFANANKR. 
The target of the Doc toxin from bacteriophage P1 (Magnuson and Yarmolinksy, 1998) was 
revised recently, in which Doc was reported to be a new type of protein kinase (instead of 
344 
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AMPylating like other Fic proteins (Kinch et al., 2009) or obstructing ribosomes (Liu et al., 
2008)) that inhibits bacterial translation by phosphorylating the conserved threonine (Thr382) 
of the translation elongation factor EF-Tu, thereby rendering it unable to bind aminoacylated 
tRNAs (Castro-Roa et al., 2013;Cruz et al., 2014). Interestingly, it was also demonstrated that 
the Phd antitoxin can only block the de novo phosporylation of EF-Tu, but cannot revert it, 
and dephosphorylation of EF-Tu was probably catalysed by the Doc toxin itself (Castro-Roa 
et al., 2013). This finding coincided with our observation, in which the inhibition of growth 
mediated by the pneumococcal Doc toxin was slowly relieved a few hours after 
overexpression (Figure 1B). It had been shown that ectopic overexpression of Doc in E. coli 
might lead to Lon-dependent activation of RelE to exhibit its mRNA cleavage activity 
(Garcia-Pino et al., 2008). Since S. pneumoniae harbors both RelBE and Phd-Doc TAs, it 
would be interesting to find out whether both TAs could cross-talk as described by Garcia-
Pino et al (Garcia-Pino et al., 2008). 
 
3.3. Morphology of E. coli and S. pneumoniae cells after toxin overexpression 
 
In many cases where overexpressed genes may cause a toxic effect, the bacterial cells change 
their morphology and may exhibit a phenotype of either filamentation or other gross changes 
in the cell shape (Scott et al., 2010). To test whether overexpression of the various toxins 
analyzed here had any influence on the cell morphology of S. pneumoniae and E. coli, 
cultures were subjected to toxin overexpression under the above conditions, and cells were 
observed using phase-contrast microscopy. In the case of S. pneumoniae no prominent 
morphological changes were observed for any cells that overexpressed the different toxins 
(Supplementary Figure S1). On the other hand, for E. coli, filamentation was observed when 
Ant or Bro were overexpressed, indicating that the cells were not dividing properly and thus 
cell growth was impaired (Figures 3C and 3D). The filamentation was not reversible for at 
least 8 h as inhibition of cell growth by Ant or Bro did not show any sign of resuming even 
after 8 h (Figure 1C). Overexpression of YoeB toxin, which likely an endoribonuclease as its 
E. coli homolog (Christensen et al., 2004;Zhang and Inouye, 2009), did not result in very 
obvious differences in morphology when compared to the wild type (Figures 3A and 3B).  
 
3.4. Other TAs in S. pneumoniae and their genetic organization 
 
3.4.1. The relBE1 operon 
 
A previous study showed that RelE1 of S. pneumoniae had no RNase activity (Christensen 
and Gerdes, 2003), but the cell growth profile after overexpression of RelE1 was not assessed. 
Here, we confirmed that expression of RelE1 was not detrimental to its homologous host or to 
the heterologous host E. coli (Figure 1) even though RelE1 shared 52% similarity with RelE2 
(in the Hungary19A-6 strain) which had been demonstrated to be functional (Nieto et al., 
2006). In spite of the high conservation of both relB1 and relE1 in all the strains (not shown), 
two (R65 and R85) out of five crucial residues responsible for RelE toxicity in Pyrococcus 
horikoshii were missing in the pneumococcal RelE1 (Takagi et al., 2005;Nieto et al., 
2010;Chan et al., 2012). In addition, truncation of relE1 in some strains, such as ATCC 
700669 and 70585 was also observed. In general, the gene arrangement around the relBE1 
genes of all the strains was similar, i.e. these genes were flanked upstream by genes that 
encode DNA polymerase III, elongation factor G and 30s ribosomal proteins, whereas 
downstream genes were found to be encoding a possible amino peptidase, an integral 
membrane protein and ribosomal small subunit pseudouridine synthase. In some instances, 
transposases were identified further upstream of relB1 (strains ATCC 700669 and INV104). 
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3.4.2.  The gene pairs xreA-ant and bro-xreB 
 
These two gene pairs were previously proposed as putative TAs in bioinformatics searches of 
the S. pneumoniae genome (Makarova et al., 1999;Chan et al., 2012). Overexpression of the 
pneumococcal Ant and Bro proteins inhibited cell growth in both S. pneumoniae and E. coli, 
but co-expression of their putative respective cognate genes xreA and xreB did not counteract 
their toxicity. However, we still do not rule out the possibility that Ant and Bro are solitary 
toxins, similar to the MazF-mx of M. xanthus, which lacks the co-transcribed antitoxin 
(Nariya and Inouye, 2008). MrpC, which is expressed from another part of the M. xanthus 
genome, serves as an antitoxin by forming complexes with MazF-mx, and it also positively 
regulates the MazF-mx expression (Nariya and Inouye, 2008). 
 
We made use of a web server designed to identify prophages (PHAST; (Zhou et al., 
2011)) to search whether pneumococcal xreA-ant and bro-xreB gene pairs were located within 
pneumococcal prophages. We found that they are located within a 94.4 kb intact prophage 
termed Streptococcus phage MM1 of S. pneumoniae Hungary19A-6 strain (Supplementary 
material). Analysis with Pfam showed that both Ant and Bro have two domains, respectively: 
Ant (232 amino acids) has an AntA (AntA/AntB antirepressor) domain at the N-terminal 
moiety and a phage antirepressor KilAC domain at the C-terminal moiety (Figure 4A); 
whereas Bro (237 amino acids) has a Bro-N domain at the N-terminus and an ORF6C (C-
terminal of bacteriophage bIL2850 ORF6) (Iyer et al., 2002) domain at the C-terminus 
(Figure 4B). Both KilA and Bro domains are widely prevalent in bacteriophages, bacteria, 
eukaryotic viruses of the nucleo-cytoplasmic large DNA virus and baculovirus classes (Iyer et 
al., 2002). A study by Kuan et al. showed that the protein ANT8 (ORF8) of lytic corynephage 
P1201 isolated from Corynebacterium glutamicum harbors a Bro domain at the N-terminus 
and an antirepressor domain at the C-terminal end 
(http://research.nchu.edu.tw/upfiles/ADUpload/oc_downmul2272130635.pdf). In this case, 
the DNA binding ability of ANT8 was contributed by the Bro domain, whereas 
overexpression of the antirepressor domain inhibited E. coli cell growth and also killed the 
cells as shown by a decrease in colony forming units. Under microscopic examination, the 
cells that overexpressed the ANT8 protein became filamentous, with irregular multiple 
nucleoids, indicating inhibition of cell division, and this result is also in agreement with our 
findings.  
 
3.5. Genomic context of the functional pneumococcal TAs relBE2 and pezAT, and their 
distribution in S. pneumoniae population 
 
The distribution of functional TAs showed a very good correlation with pneumococcal STs 
and CCs (Table 2). As described in our previous report, RelBE2 is present in all the 48 
pneumococcal database strains with seven out of them having two copies. Moreover, six 
different gene organizations were found for this TA (Chan et al., 2012) that fall into two 
groups, encompassing the previously defined Types I-IV and Types V-VI (Chan et al., 2012; 
Figure 5A). The latter are flanked by xre upstream and COG2856B downstream, an 
arrangement that is not observed in Types I-IV. RelE2 of Types V and VI were also clustered 
together in the phylogenetic analyses (Figure 5B). In addition, in strains with two copies of 
RelBE2, one copy belonged to Types I-IV whereas the second copy belonged to either Type 
V or VI. Integrases and IS elements were evident in Types III-VI. The particular gene 
 10
 451 
452 
453 
454 
455 
456 
457 
458 
459 
460 
461 
462 
463 
464 
465 
466 
467 
468 
469 
470 
471 
472 
473 
474 
475 
476 
477 
478 
479 
480 
481 
482 
483 
484 
485 
486 
487 
488 
489 
490 
491 
492 
493 
494 
495 
496 
497 
498 
499 
500 
arrangement showed also a very good agreement with STs and CCs, with a single exception 
in the Taiwan19F-14 international clone (Table 2). All these observations suggest that the 
second copy of relBE2 may likely be horizontally acquired by some strains rather than 
represent a product of gene duplication. 
 
 In our previous bioinformatics search, 28 out of the 48 annotated pneumococcal 
strains harbored a single copy of pezAT; whereas three strains harbored two copies (Chan et 
al., 2012). The two copies of pezAT within the same strain were almost identical (similarities 
of 96-97%), and the catalytically important residues (Meinhart et al., 2003) were also 
conserved. The gene organization of pezAT among the various S. pneumoniae strains is even 
more varied than relBE2. This TA is flanked by a number of genes that contribute to site-
specific recombination and even genes that play roles in conjugative transfer. The pezAT 
locus is known to be present on a genomic island known as the pneumococcal pathogenicity 
island 1 (Meinhart et al., 2003;Nieto et al., 2006) but interestingly, a search using a web-based 
resource for bacterial ICEs known as ICEberg database led us to discover the presence of a 
previously unreported pezAT operon in a putative pneumococcal ICE designated Tn5253 
(Ayoubi et al., 1991). This was corroborated when a recent analysis of the complete sequence 
of Tn5253 from S. pneumoniae DP1322 indicated the presence of two copies of pezAT 
(Iannelli et al., 2014) which comprised part of a 1,169 bp direct repeat that flanks the 
Ωcat(pC194) element within Tn5253. Experimental evidence showed that excision of 
Ωcat(pC194) from Tn5253 occurred by a recombination event within the pezAT-containing 
repeat segment leaving one copy in Tn5253 and another copy in the newly-excised plasmid 
pC194 (Iannelli et al., 2014). Besides that, ectopic integration of Ωcat(pC194) to other 
regions of the S. pneumoniae genome was also detected, likely by homologous recombination 
involving the pezAT-containing direct repeat segments (Iannelli et al., 2014). Thus, pezAT 
appeared to play a direct role in the transfer of the Ωcat(pC194) element and may also help in 
the stable maintenance of this element in its hosts. It is therefore not surprising that 
phylogenetic analyses showed that PezAT found in Tn5253 formed a separate cluster from 
PezAT located in the pneumococcal pathogenicity island 1 (Supplementary Figure S2 and 
Table S1).  
 
3.6. Conclusions  
 
Previous searches for putative type II TAs in S. pneumoniae (Chan et al., 2012;Chan et al., 
2013) led us to conclude that their number was greatly undervalued. However, our present in 
vivo validation has shown that, indeed, only four of the TAs, namely RelBE2 (Nieto et al., 
2006), YefM-YoeB (Nieto et al., 2007;Chan et al., 2011), PezAT (Khoo et al., 
2007;Mutschler et al., 2011) and now, Phd-Doc can be considered as bona fide TAs in the 
‘classical’ sense that the harmful effects of the toxins must be counteracted by their cognate 
antitoxins and that their two genes should be organized as an operon (Gerdes, 2013). 
Bioinformatics search approaches have helped us to identify various putative TA homologs; 
however, the actual number of bona fide TAs might be overestimated as in our case e.g. 
pneumococcal relBE2 is functional TA but pneumococcal relBE1 is apparently not. In the 
case of M. tuberculosis, of the 88 putative TAs identified, only 30 are functional (Ramage et 
al., 2009). Other approaches like shotgun cloning as presented by Sberro et al (Sberro et al., 
2013) could be another alternative and more thorough approach to identify TAs. However, 
there might be more TAs than these four if we consider Ant and Bro as possible solo toxins 
whose respective antitoxins might be located elsewhere in the pneumococcal chromosome. 
The finding that these two novel proteins might be associated with lysogenic bacteriophages 
is, indeed, appealing and merits an in-depth study of their features. 
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Legends to the figures 
 
Figure 1. Overexpression of pneumococcal putative TAs. (A) Overexpression of 
pneumococcal putative toxins in homologous host S. pneumoniae had shown that HicA, 
RelE1, COG2856CA and COG2856C were not harmful to the cells; whereas overexpression 
of Doc, Ant and Bro had thwarted cell growth but resumed a few hours albeit slowly. (B) 
Since Doc, Ant and Bro were toxic to the cells, they were thus further analyzed to ensure if 
their putative cognate antitoxins were functional as well in S. pneumoniae host. For Doc, co-
expression of its cognate antitoxin Phd in cis had neutralized the Doc toxicity to the cell, 
signifying Phd-Doc is a functional TA. On the other hand, overexpression of Ant and Bro 
repressed the growth of the cells but co-expression of their cognate putative antitoxins XreA 
and XreB, respectively, were not able to neutralize the toxic effect of the toxins, and instead 
more toxic to the cells. Note that XreA or XreB alone was inert to the cells. Thus, we have 
ruled out that XreA-Ant and Bro-XreB are typical TAs. (C) Overexpression assays in 
heterologous host E. coli. Similar to the natural host S. pneumoniae, overexpression of 
pneumococcal putative toxins HicA, RelE1, COG2856CA and COG2856C did not affect cell 
growth. Unfortunately we were not able to construct doc toxin in pFUS2SD plasmid likely 
due to its high toxicity. YoeB from strain R6, which is a known functional pneumococcal 
toxin (Nieto et al., 2007;Chan et al., 2011) was used as a positive control (pFUS2SD_YoeB), 
whereas pFUS2SD without insert served as a negative control. As with the pneumococcal 
YoeB toxin, overexpression of pneumococcal Ant and Bro inhibited growth of E. coli and no 
recovery was observed even after 8 h of incubation, which was in contrary to the results in S. 
pneumoniae, in which cell growth was resumed a few hours after toxins overproduction. 
 
Figure 2. Gene organization and expression of the pneumococcal phd-doc locus. (A) The 
pneumococcal phd-doc is surrounded by genes that encode Type I restriction-modification 
(RM) proteins and integrase/recombinase. The pneumococcal phd antitoxin gene is located 
upstream of its cognate toxin gene doc, and both genes overlap by 4 nucleotides. A promoter 
and a Shine-Dalgano (SD) were identified upstream of phd, and an inverted repeat (denoted 
by arrows) was found overlapping the ‒35 sequences (boxed); the ‒10 region of the putative 
promoter and the SD sequences are also boxed. The stop codon of Phd is underlined and the 
start codon of Doc is indicated in overline. (B) Expression and self-regulation of the phd-doc 
operon. Cultures (1 ml) of S. pneumoniae R6 cells harboring recombinant plasmids were 
grown until an OD650~0.3. Cells were harvested, resuspended in 1× PBS buffer and their 
fluorescence was measured. Plasmids used were: pAST_P, harboring only the promoter of the 
operon; pAST_PPhd, harboring the promoter and the phd gene; pAST_PPhdDoc, harboring 
the entire phd-doc operon, and the promoter-less gfp plasmid vector, pAST, used as control. 
Standard errors (average of three independent experiments) are indicated. (C) Cells 
examination under phase-contrast and fluorescence microscopy. The GFP level for cells 
harboring pAST_P (a) and pAST_PPhd (b) did not show much difference; whereas GFP level 
for pAST_PPhdDoc (c) was visibly lower, which is coincided with the fluorescence 
measurement. Cells harboring plasmid pAST served as negative control. 
 
Figure 3. Morphology of E. coli cells under microscope at 100× magnification after 
overexpression of the respective pneumococcal toxins. Morphology of the cells which 
harbor (A) the negative control pFUS2SD, (B) the positive control pFUS2SD_YoeB, (C) 
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pFUS2SD_Ant and (D) pFUS2SD_Bro, were examined after 8 h of overexpression. 
Filamented cells were observed in cultures overexpressing Ant or Bro, but no prominent 
differences were found for cells overexpressing YoeB when compared to wild type. 
 
Figure 4. The domains of pneumococcal Ant and Bro toxins. Sequence analyses from 
Pfam showed that (A) pneumococcal Ant harbors two domains, with the AntA domain at the 
N-terminus and KilAC domain at the C-terminus; whereas (B) pneumococcal Bro harbors a 
Bro-N domain at the N-terminal and an ORF6C domain at the C-terminal. 
 
Figure 5. Gene organization and phylogenetic analyses of pneumococcal RelE2 
homologs. (A) Polymorphisms associated with the gene organization of relBE2 and their 
neighboring genes found in 48 pneumococcal strains. Six variations of gene organizations 
were found (Type I-VI). In general, the relBE2 operon was flanked upstream by vicX (metal-
dependent hydrolase), whereas a RUP (repeat unit of pneumococcus), element, ldh (lactate 
dehydrogenease), and gyrA (the A subunit of DNA gyrase) are located downstream for Type 
I-IV. For Type V-VI, the relBE2 cassette is flanked upstream by xre-like protein and 
COG2856B downstream. Mobile elements are seen in Types III-VI. Other abbreviations used: 
restriction-modification (RM); restriction-endonuclease (RE); hypothetical protein (HP). (B) 
Phylogenetic analyses of RelE2 homologs with neighbor-joining algorithm, in which the 
determined start codon of relE2 was considered (Moreno-Córdoba et al., 2012), had shown 
that Type V and Type VI gene organizations of RelE2 cluster together, indicating RelE2 from 
both types are of more similar in sequences. The type of relBE2 gene organization was 
indicated. For the strain Canada MDR 19F, the type of gene arrangement is unknown due to 
data unavailability in the NCBI databases. 
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 Table 1. Recombinant plasmids used in this study 
 
Plasmids  Descriptions and primers used 
pFUS2 (Lemonnier et al., 2003) A 4.5 kb vector with ori-pBR322 which harbors an arabinose-inducible PBAD promoter upstream of a multiple cloning site 
pFUS2SD An SD consensus ´AGGAGG´ was inserted downstream of PBAD promoter and upstream of EcoRI restriction site of pFUS2 
plasmid. This recombinant plasmid was used for the cloning of putative toxins from S. pneumoniae Hungary19A-6 and 
subsequently for overexpression assays in E. coli Top10  
Forward primer: 5´-GGGCTAGCGAATTCGAGCTC-3´ 
Reverse primer: 5´-GATCGAATTCCCTCCTGCTAGCCCAAAAAAACGG -3´ 
pFUS2SD_YoeB pFUS2SD with yoeB from S. pneumoniae R6; as positive control in overexpression assays in E. coli Top10 
Forward primer: 5´-GATAGAATTCATGCTACTCAAGTTTACAGA-3´ 
Reverse primer: 5´- GACAAAGCTTTTAGTAATGATCTTTAAAGG-3´ 
pFUS2SD_ RelE1 pFUS2SD with relE1 from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCGTGCTTAAGATTCGTTATCA-3´ 
Reverse primer: 5´-TCATAAGCTTTTAAAATAAATCACTGTGAC-3´ 
pFUS2SD_ HicA pFUS2SD with hicA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCATGCCTATGACACAAAAAGA-3´ 
Reverse primer: 5´-TCATAAGCTTGCAGGGGCTGAATTTTACAA-3´ 
pFUS2SD_ COG2856CA pFUS2SD with COG2856CA gene from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCATGGATTTAAGTAATAAAGC-3´ 
Reverse primer: 5´-TTGTAAGCTTTTATCCTAATGACATTTCCT-3´ 
pFUS2SD_ COG2856B pFUS2SD with COG2856B gene from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCATGACTGAAAAAGAATTTTC-3´ 
Reverse primer: 5´-TCATAAGCTTTTAATTAAGTAGTGCTAAAT-3´ 
pFUS2SD_ Ant pFUS2SD with ant from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCATGAACGAACTCATCAACGT-3´ 
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 Reverse primer: 5´-TCATAAGCTTCTAATTAAGGAACTTATCGA-3´ 
pFUS2SD_ Bro pFUS2SD with bro from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAGAATTCATGAACGAAATTTTTAATTT-3´ 
Reverse primer: 5´-TCATAAGCTTCTACCCTTCGTCAAATGAGT-3´ 
pLS1ROM-MCS (Lacks et al., 
1986;Ruiz-Masó et al., 2012) 
A 6.8 k vector derived from plasmid pLS1 that harbors a maltose-inducible PM promoter upstream of a multiple cloning site. This 
plasmid was used for the cloning of putative TAs from S. pneumoniae Hungary19A-6  and subsequently for overexpression assays 
in S. pneumoniae R6 
pLS1ROM_HicA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-AGTAAAGCTTGGTGTTGTCAGGAGGTAAAA-3´ 
Reverse primer: 5´-AGTCACTAGTGAATTTTACAACCCAGCTTG-3´ 
pLS1ROM_RelE1 pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GTAGAAGCTTATTTGATGGAGGACTTACG-3´ 
Reverse primer: 5´-AGTCACTAGTGAGAACCCCCTTAAAATAGA-3´ 
pLS1ROM_ COG2856CA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GTAGAAGCTTGGAAAAAGGTGAAAGGAATA-3´ 
Reverse primer: 5´-AGTCACTAGTTTCCTCATACTTCCCTTGCG-3´ 
pLS1ROM_ COG2856B pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GTACAAGCTTAGAAAGCAATAATAATAAAA-3´ 
Reverse primer: 5´-AGTCACTAGTTTTTCTCTCCTTTTTTAATT-3´ 
pLS1ROM_XreA pLS1ROM-MCS with xreA from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GATCCCAAGCTTCTATTATTTGTCAATGAATA-3´ 
Reverse primer: 5´-GATCCCACTAGTTTATTCCTCCAGCAATTGTT-3´ 
pLS1ROM_Ant pLS1ROM-MCS with ant from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GATCCCAAGCTTTTCAATTGCAAATTATTTAA-3´ 
Reverse primer: 5´-GATCCCACTAGTCTAATTAAGGAACTTATCGA-3´ 
pLS1ROM_XreA-Ant pLS1ROM-MCS with xreA-ant from S. pneumoniae Hungary19A-6 
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 Forward primer: 5´-GATCCCAAGCTTCTATTATTTGTCAATGAATA-3´ 
Reverse primer: 5´-GATCCCACTAGTCTAATTAAGGAACTTATCGA-3´ 
pLS1ROM_XreB pLS1ROM-MCS with xreB from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GATCCCAAGCTTAGCACTAATACCAAGATGAA-3´ 
Reverse primer: 5´-GATCCCACTAGTTTATATTTGATTAGAGAGCC-3´ 
pLS1ROM_Bro pLS1ROM-MCS with bro from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GATCCCAAGCTTACACGATTATTCACCCCTTG-3´ 
Reverse primer: 5´-GATCCCACTAGTCTACCCTTCGTCAAATGAGT-3´ 
pLS1ROM_Bro-XreB pLS1ROM-MCS with bro-xreB from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GATCCCAAGCTTACACGATTATTCACCCCTTG-3´ 
Reverse primer: 5´-GATCCCACTAGTTTATATTTGATTAGAGAGCC-3´ 
pLS1ROM_Phd pLS1ROM-MCS with phd from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GAGCGGCCGCAGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3´ 
Reverse primer: 5´-CAGCGGATCCTCATTTTTCCACCAAAGCTT-3´ 
pLS1ROM_Doc pLS1ROM-MCS with doc from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GAGCGGCCGCAGGAGGAAATCAGATGACAATCTATTTGACAGA-3´ 
Reverse primer: 5´-CAGCGGATCCTTACTTTTTGACCTTTTCTC-3´ 
pLS1ROM_Phd-Doc pLS1ROM-MCS with phd-doc from S. pneumoniae Hungary19A-6 
Forward primer: 5´-GAGCGGCCGCAGGAGGAAATCAGATGGTAGTAAAAACAAGAAA-3´ 
Reverse primer: 5´-CAGCGGATCCTTACTTTTTGACCTTTTCTC-3´ 
pAST (Ruiz-Cruz et al., 2010) A 5.5 kb vector derived from plasmid pMV158 that harbors a multiple cloning site between the E. coli T1T2rrnB terminator 
region and the promoter-less gfp gene 
pAST_P A 231 bp of DNA encompassing the putative promoter of phd-doc from S. pneumoniae Hungary19A-6 was inserted upstream of 
the gfp gene of pAST plasmid. 
Forward primer: 5´-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3´ 
Reverse primer: 5´-CAGCGAGCTCCTGATTTCCTCCTTTGAAGT-3´ 
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pAST_PPhd A 471 bp of DNA encompassing the putative promoter of phd-doc and phd gene from S. pneumoniae Hungary19A-6 was inserted 
upstream of the gfp gene of pAST plasmid. 
Forward primer: 5´-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3´ 
Reverse primer: 5´-CAGCGAGCTCTTGTCATTTTTCCACCAAAG-3´ 
pAST_PPhd An 878 bp of DNA encompassing the putative promoter of phd-doc and phd-doc genes from S. pneumoniae Hungary19A-6 was 
inserted upstream of the gfp gene of pAST plasmid. 
Forward primer: 5´-CAGAGGATCCCTGTTGGAAATGTAGCGTAC-3´ 
Reverse primer: 5´-CAGCGAGCTCTTACTTTTTGACCTTTTCTC-3´ 
  
*The underlined sequences were the restriction sites used for cloning 
 Table 2. Distribution of sequence types, clonal complexes, and functional TAs in S. 
pneumonia 
 
Strain (N = 48) 
 
Sequence 
Type 
Clonal 
Complex 
Phd-Doc 
 
YefM-YoeB 
 
PezAT 
 
RelBE2a 
(Type) 
Total 
 
INV200 9 15 1 1 1 1 (II) 4 
BS397 13 15 1 1 1 1 (II) 4 
BS455 2011 15 1 1 1 1 (II) 4 
BS457 13 15 1 1 1 1 (II) 4 
BS458 13 15 1 1 1 1 (II) 4 
SP-BS293 13 15 1 1 1 1 (II) 4 
SP14-BS292 13 15 1 1 1 1 (II) 4 
CGSP14 15 15 1 1 2 1 (II) 5 
AP200 62 62 1 1  1 (II) 3 
MLV-016 62 62 1 1  1 (II) 3 
SP11-BS70 62 62 1 1   1 (II) 3 
G54 63 63 1     1 (II) 2 
JJA 66 66 1 1 1 2 (II&V) 5 
ATCC 700669 81 81 1  2 2 (II&V) 5 
670-6B 90 90 1 1 1 1 (II) 4 
GA41317 2705 100   1   1 (II) 2 
OXC141 180 180 1  1 1 (II) 3 
SP3-BS71 180 180 1   1 1 (II) 3 
CDC1087-00 191 191 1 1   1 (II) 3 
CDC3059-06 199 199 1   1 2 (I&V) 4 
TIGR4 205 205 1 1 1 1 (I) 4 
P1031 303 217 1   2 2 (II&VI) 5 
CDC0288-04 220 218   1 1 1 (IV) 3 
GA41301 242 242 1 1 1 2 (II&V) 5 
70585 289 289 1   1 1 (II)  3 
INV104 227 306 1 b  1 (II) 2 
GA47901 304 306 1    1 (II) 2 
GA04375 236 320 1   1 (IV) 2 
Taiwan19F-14 236 320 1   1 (IV) 2 
str. Canada MDR_19A 320 320 1   1 (II) 2 
str. Canada MDR_19F 320 320 1   1c 2 
TCH8431/19A 320 320 1   1 (IV) 2 
SP19-BS75 485 395 1 1 1 1 (II) 4 
SP23-BS72 37 439   1 1 1 (II) 3 
SP6-BS73 460 460 1   1 1 (I) 3 
GA17545 9057 1536 1     1 (II) 2 
CDC1873-00 376 2090 1 1 1 2 (II&V) 5 
GA47368 1339 2090 1 1 1 2 (II&V) 5 
CCRI 1974 124 L_124 1   1 (II) 2 
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CCRI 1974M2 124 L_124 1   1 (II) 2 
SP14-BS69 124 L_124 1   1 1 (II) 3 
SP18-BS74 146 L_146 1     1 (II) 2 
GA17570 156 L_156 1 1 1 1 (III) 4 
SP195 156 L_156 1 1 1 1 (III) 4 
SP9-BS68 1269 L_162 1 1 1 1 (III) 4 
Hungary 19A-6 268 L_176 1 1 1 1 (II) 4 
D39 595 singleton  1 1 1 (I) 3 
R6 595 singleton  1 1 1 (I) 3 
 
aThe organization types (I-VI) of the RelBE2-TA are indicated within parenthesis. 
bThere is a stop codon within YoeB (only 15 amino acid residues are translated) of strain INV104, and thus 
YefM-YoeB of this strain was excluded in this table. 
cData not available for analyses.  
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